Ligand Pharma (LGND) PT Raised to $119 at Deutsche Bank

May 9, 2018 7:39 AM EDT Send to a Friend
Deutsche Bank raised its price target on Ligand Pharma (NASDAQ: LGND) to $119.00 (from $115.00) while maintaining a Sell rating.Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login